Invesco Health Care Fund Class C (GTHCX)
| Fund Assets | 1.23B |
| Expense Ratio | 1.81% |
| Min. Investment | $1,000 |
| Turnover | 59.00% |
| Dividend (ttm) | 2.20 |
| Dividend Yield | 13.53% |
| Dividend Growth | 20.01% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 18, 2025 |
| Previous Close | 16.28 |
| YTD Return | -5.52% |
| 1-Year Return | 4.75% |
| 5-Year Return | 12.55% |
| 52-Week Low | 15.75 |
| 52-Week High | 20.59 |
| Beta (5Y) | n/a |
| Holdings | 78 |
| Inception Date | Mar 1, 1999 |
About GTHCX
The Invesco Health Care Fund Class C is an actively managed mutual fund focused on achieving long-term capital growth by investing primarily in the equity securities of healthcare companies. Its portfolio includes common and preferred stocks, as well as depositary receipts, with exposure to both domestic and international firms. The fund targets a broad range of healthcare industries, such as pharmaceuticals, biotechnology, medical devices, and healthcare services, providing diversified access to one of the world's most dynamic sectors. With a management fee and total annual operating expenses that reflect its specialized strategy, the fund aims to capture growth opportunities driven by medical advancements, demographic trends, and evolving global healthcare needs. It plays a significant role in the market by offering investors a way to participate in the long-term innovation and expansion of the healthcare sector, while also managing the specific risks associated with industry and global exposures.
Performance
GTHCX had a total return of 4.75% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.37%.
Top 10 Holdings
44.66% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.55% |
| Boston Scientific Corporation | BSX | 5.10% |
| AbbVie Inc. | ABBV | 5.02% |
| Cencora, Inc. | COR | 4.73% |
| Gilead Sciences, Inc. | GILD | 3.89% |
| AstraZeneca PLC | AZN | 3.80% |
| argenx SE | ARGX | 3.62% |
| Johnson & Johnson | JNJ | 3.41% |
| McKesson Corporation | MCK | 3.21% |
| Thermo Fisher Scientific Inc. | TMO | 2.33% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 18, 2025 | $2.2025 | Dec 18, 2025 |
| Dec 16, 2024 | $1.8353 | Dec 16, 2024 |
| Dec 16, 2021 | $9.9297 | Dec 16, 2021 |
| Dec 15, 2020 | $0.4666 | Dec 15, 2020 |
| Dec 13, 2019 | $1.3703 | Dec 13, 2019 |
| Dec 14, 2018 | $2.9024 | Dec 14, 2018 |